Cipher Pharmaceuticals Inc. (OTCMKTS:CPHRF – Get Free Report) (TSE:CPH)’s stock price passed above its 50 day moving average during trading on Friday . The stock has a 50 day moving average of $10.40 and traded as high as $10.90. Cipher Pharmaceuticals shares last traded at $10.90, with a volume of 2,734 shares.
Cipher Pharmaceuticals Trading Up 0.1%
The business has a 50-day moving average price of $10.40 and a 200 day moving average price of $10.43.
Cipher Pharmaceuticals Company Profile
Cipher Pharmaceuticals Inc is a specialty pharmaceutical company that develops, acquires and commercializes prescription products in respiratory and dermatology markets. Founded in 2004 and headquartered in Vancouver, British Columbia, the company focuses on in-licensing established therapies and launching them under its own commercial infrastructure in North America.
In the respiratory segment, Cipher markets generic inhalation therapies for conditions such as asthma and chronic obstructive pulmonary disease (COPD).
Further Reading
- Five stocks we like better than Cipher Pharmaceuticals
- Best $19 you’ll spend this year.
- Do not delete, read immediately
- How a Family Trust May Be Able To Help Preserve Your Wealth
- Wall Street Stockpicker Names #1 Stock of 2026
- Buy this stock tomorrow?
Receive News & Ratings for Cipher Pharmaceuticals Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Cipher Pharmaceuticals and related companies with MarketBeat.com's FREE daily email newsletter.
